MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
Open accessThe DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
Signaling through the adaptor protein myeloid differentiation factor 88 (MyD88) promotes carcinogenesis in several cancer models. In contrast, MyD88 signaling has a protective role in the development of azoxymethane (AOM)/dextran sodium sulfate (DSS) colitis-associated cancer (CAC). The inability of Myd88(-/-) mice to heal ulcers generated upon injury creates an altered inflammatory environment that induces early alterations in expression of genes encoding proinflammatory factors, as well as pathways regulating cell proliferation, apoptosis, and DNA repair, resulting in a dramatic increase in adenoma formation and progression to infiltrating adenocarcinomas with frequent clonal mutations in the beta-catenin gene. Others have reported that toll-like receptor (Tlr) 4-deficient mice have a similar susceptibility to colitis to Myd88-deficient mice but, unlike the latter, are resistant to CAC. We have observed that mice deficient for Tlr2 or Il1r do not show a differential susceptibility to colitis or CAC. However, upon AOM/DSS treatment Il18(-/-) and Il18r1(-/-) mice were more susceptible to colitis and polyp formation than wild-type mice, suggesting that the phenotype of Myd88(-/-) mice is, in part, a result of their inability to signal through the IL-18 receptor. This study revealed a previously unknown level of complexity surrounding MyD88 activities downstream of different receptors that impact tissue homeostasis and carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, IL-18 KO or IL-18R KO mice are also highly sensitive to colitis-associated CRC [124,125].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · cited 4×
“We observed enhanced expression of several known STAT3-dependent genes (Yu et al., 2009) in addition to Il6 and Il11 in AOM/DSS-treated Myd88/ mice, including Cox2, Hif1a, and several metalloproteases.”
BackgroundInfluentialRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 2×
“RESULTS Myd88/ mice show increased susceptibility to develop colonic tumors after AOM/DSS administration Myd88/ mice are highly susceptible to the development of colitis induced by irradiation or DSS as a result of reduced ability to repair the mucosal integrity after injury with significant morbidity and mortalit…”
BackgroundIKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155 · cited 2×
“STAT3 activation in both epithelial cells and in stromal and infiltrating cells has been shown to regulate the tumor inflammatory environment as well as to have direct effects on the tumor itself by inducing antiapoptotic, proangiogenic, and proproliferative gene expression programs (Grivennikov et al., 2009; Yu et al…”
BackgroundSystematic variation in gene expression patterns in human cancer cell lines
Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., et al. (2000) · Nature Genetics · doi:10.1038/73432 · Cited by 2,088
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617 · cited 2×
“…and Il18/ mice to colon carcinogenesis might exclusively be the result of the lack of an immunosurveillance effect of adaptive immunity and IFN- (Dunn et al., 2006), particularly when it is considered that Rag/ immunodeficient mice have reduced rather than increased susceptibility to colon…”
BackgroundStabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., & Polakis, P. (1997) · Science · doi:10.1126/science.275.5307.1790 · Cited by 1,223
Cited by
Items 101–200 of 451
Deregulated inflammasome signaling in disease
Lamkanfi, M., Walle, L. V., & Kanneganti, T. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01042.x · Cited by 155
“Moreover, il-18 ⁄ ) and il-18r1 ⁄ ) mice were protected against tissue damage in the DSS-induced colitis and the AOM ⁄DSS tumorigenesis models (107).”
BackgroundToll-like receptor signaling in colorectal cancer: Carcinogenesis to cancer therapy
Li, T.-T., Ogino, S., & Qian, Z. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17699 · Cited by 145
Niederreiter, L., Fritz, T. M. J., Adolph, T. E., Krismer, A.-M., Offner, F. A., Tschurtschenthaler, M., Flak, M. B., Hosomi, S., Tomczak, M. F., Kaneider, N. C., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122341 · Cited by 139
“…Xbp1 suppresses tumor formation in Apcmin/+ mice Inflammatory signaling is an important contributor to CAC but also to sporadic and familial CRC (Rakoff-Nahoum and Medzhitov, 2007; Lee et al., 2010), with overlapping and distinct inflammatory pathways being involved (Salcedo et al., 2010).”
BackgroundZhou, C., & Fang, J. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.001 · Cited by 161
Context-dependent functions of pattern recognition receptors in cancer
Man, S. M., & Jenkins, B. J. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00462-5 · Cited by 151
Diverse roles of STING-dependent signaling on the development of cancer
Ahn, J., Konno, H., & Barber, G. N. (2015) · Oncogene · doi:10.1038/onc.2014.457 · Cited by 141
Epithelial Cell Inflammasomes in Intestinal Immunity and Inflammation
Lei, A., Murphy, A. G., & Maloy, K. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01168 · Cited by 150
“Conversely, independent studies using IL-18- and IL-18Rdeficient mice revealed a beneficial role for IL-18 signaling during DSS colitis (Table 2) (127, 128).”
BackgroundAsquith, M., & Powrie, F. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101330 · Cited by 136
Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease
Lopetuso, L. R., Chowdhry, S., & Pizarro, T. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00181 · Cited by 133
Li, X., Zhang, Z., Li, L., Gong, W., Lazenby, A. J., Swanson, B. J., Herring, L. E., Asara, J. M., Singer, J. D., & Wen, H. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161105 · Cited by 144
“The bleeding score and diarrhea score were calculated as previously described (Allen et al., 2010; Salcedo et al., 2010).”
MethodInterleukins 1 and 6 as main mediators of inflammation and cancer
Dmitrieva, O., Shilovskiy, I. P., Khaitov, M. R., & Grivennikov, S. I. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916020024 · Cited by 158
Innate immune mediators in cancer: between defense and resistance
Berraondo, P., Minute, L., Ajona, D., Corrales, L. P., Melero, I., & Pío, R. (2016) · Immunological Reviews · doi:10.1111/imr.12464 · Cited by 147
Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
Kantono, M., & Guo, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01132 · Cited by 133
Ahechu, P., Zozaya, G., Martí, P., Hernández-Lizoáin, J. L., Baixauli, J., Unamuno, X., Frühbeck, G., & Catalán, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02918 · Cited by 143
“Whereas, during early stages of CC IL-18 exerts a protective role including epithelial repair processes (177) during later stages, it promotes tumor growth and cellular invasion (178).”
BackgroundSebastian, S., Hernández, V., Myrelid, P., Kariv, R., Tsianos, E. V., Törüner, M., Martí, M., Spinelli, A., Jong, A. E. V. D. M., Yüksel, E. S., et al. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.04.008 · Cited by 143
IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer
Voronov, E., & Apte, R. N. (2015) · Cancer Microenvironment · doi:10.1007/s12307-015-0177-7 · Cited by 139
Deubiquitination of NLRP6 inflammasome by Cyld critically regulates intestinal inflammation
Mukherjee, S. K., Kumar, R., Tsakem, E. L., Basrur, V., Kontoyiannis, D. L., Ioakeimidis, F., Mosialos, G., Theiss, A. L., Flavell, R. A., & Venuprasad, K. (2020) · Nature Immunology · doi:10.1038/s41590-020-0681-x · Cited by 133
Hu, S., Peng, L., Kwak, Y.-T., Tekippe, E. M., Pasare, C., Malter, J. S., Hooper, L. V., & Zaki, M. H. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.040 · Cited by 121
NOD2 Suppresses Colorectal Tumorigenesis via Downregulation of the TLR Pathways
Udden, S. M. N., Peng, L., Gan, J., Shelton, J. M., Malter, J. S., Hooper, L. V., & Zaki, H. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.084 · Cited by 129
“On the other hand, MyD88−/− mice were shown to be highly susceptible to chemical injury-induced colitis and colorectal tumorigenesis (Salcedo et al., 2010).”
BackgroundMicrobiota in cancer development and treatment
Raza, M. H., Gul, K., Arshad, A., Riaz, N., Waheed, U., Rauf, A., Aldakheel, F. M., Alduraywish, S. A., Rehman, M. U., Abdullah, M., et al. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2816-0 · Cited by 129
Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer
Lin, C., Cai, X., Zhang, J., Wang, W., Sheng, Q., Hua, H., & Zhou, X. (2018) · Digestion · doi:10.1159/000494052 · Cited by 125
Targeting Innate Immunity in Cancer Therapy
Rameshbabu, S., Labadie, B. W., Argulian, A., & Patnaik, A. (2021) · Vaccines · doi:10.3390/vaccines9020138 · Cited by 129
Mechanisms of Immune Signaling in Colitis-Associated Cancer
Waldner, M. J., & Neurath, M. F. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2014.11.006 · Cited by 118
Hofman, P., Cherfils-Vicini, J., Bazin, M., Ilie, M., Juhel, T., Hébuterne, X., Gilson, E., Schmid-Alliana, A., Boyer, O., Adriouch, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1778 · Cited by 109
“However, downregulation of IL1B and STAT3 phosphorylation could not represent the solemechanismas it has been reported that genetic inactivation of IL1BR or of STAT3 in the intestinal epithelial cell compartment (DIEC mice) decreased tumor development (35, 36).”
BackgroundGut Microbiota Protects against Gastrointestinal Tumorigenesis Caused by Epithelial Injury
Zhan, Y., Chen, P.-J., Sadler, W. D., Wang, F., Poe, S., Núñez, G., Eaton, K. A., & Chen, G. Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0827 · Cited by 107
“mice have been previously reported to have more tumors than SPF WTmice with a higher concentration of DSS than used in the current study (48), and may be explained in part by the presence of commensal bacteria driving inflammation and tumorigenesis in SPF MyD88 KO mice.”
Multiple Roles of Toll-Like Receptor 4 in Colorectal Cancer
Yesudhas, D., Gosu, V., Anwar, M. A., & Choi, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00334 · Cited by 124
Targeting pattern recognition receptors in cancer immunotherapy
Goutagny, N., Estornes, Y., Hasan, U. A., Lebecque, S., & Caux, C. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0213-1 · Cited by 122
“Moreover, several studies have shown that TLRs, as other PRR indeed [50], are capable of controlling intestinal epithelial homeostasis through proliferation and protection from injury [51, 52].”
BackgroundNLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease
Tye, H., Yu, C.-H., Simms, L. A., de Zoete, M. R., Kim, M. L., Zakrzewski, M., Penington, J. S., Harapas, C. R., Souza-Fonseca-Guimaraes, F., Wockner, L. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06125-0 · Cited by 110
Kirkland, D., Benson, A., Mirpuri, J., Pifer, R., Hou, B., DeFranco, A. L., & Yarovinsky, F. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.019 · Cited by 110
“It is well known that the lack of MyD88 in all cell types results in rapid mortality after DSS treatment in mice (Abraham andMedzhitov, 2011; Saleh and Elson, 2011).”
BackgroundInterleukin-18: a regulator of cancer and autoimmune diseases
Esmaeilbeig, M., & Ghaderi, A. A. (2017) · European Cytokine Network · doi:10.1684/ecn.2018.0401 · Cited by 119
“Decreased expression of IL-18 in colon cancer in other studies and increased colitis, polyp formation, and colorectal cancer in IL-18-/- mice suggest antitumoral activity of IL-18 in colorectal malignancies [28, 29].”
BackgroundInflammasomes in Inflammation-Induced Cancer
Lin, C., & Zhang, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00271 · Cited by 120
“Deficiency of any downstream mediator in IL-18 pathway like MYD88 is more susceptible to intestinal hyperproliferation and carcinogenesis (186).”
BackgroundSaud, S. M., Young, M. R., Jones‐Hall, Y., Ileva, L. V., Evbuomwan, M. O., Wise, J., Colburn, N. H., Kim, Y. S., & Bobe, G. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0525 · Cited by 103
“This pathway is also activated in the AOM/DSS mouse model (19, 27).”
BackgroundXie, L., Jiang, F.-C., Zhang, L.-M., He, W.-T., Liu, J.-H., Li, M.-Q., Zhang, X., Xing, S., Guo, H., & Zhou, P. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv364 · Cited by 97
IL-1 Signaling in Tumor Microenvironment
Zhang, W., Borcherding, N. C., & Kolb, R. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38315-2_1 · Cited by 107
MyD88 and its divergent toll in carcinogenesis
Salcedo, R., Cataisson, C., Hasan, U., Yuspa, S. H., & Trinchieri, G. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.008 · Cited by 94
Self-citationIntegrative inflammasome activity in the regulation of intestinal mucosal immune responses
Elinav, E., Henao‐Mejia, J., & Flavell, R. A. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.115 · Cited by 107
The emerging roles of inflammasome‐dependent cytokines in cancer development
Gorp, H. V., & Lamkanfi, M. (2019) · EMBO Reports · doi:10.15252/embr.201847575 · Cited by 104
“…and cytotoxic T-cell (CD8 + T cells) responses [105,115,116], mice lacking IL-18 or its cognate receptor were reported to be hypersusceptible to colitis-associated tumorigenesis in the murine azoxymethane (AOM)/ dextran sodium sulphate (DSS) model of inflammation-associated colorectal cancer [117].”
The Dual Role of Inflammation in Colon Carcinogenesis
Monteleone, G., Pallone, F., & Stolfi, C. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911071 · Cited by 106
Wang, T., Pan, D., Zhou, Z., You, Y., Jiang, C., Zhao, X., & Lin, X. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005662 · Cited by 97
Klimesova, K., Kverka, M., Zakostelska, Z., Hudcovic, T., Hrncir, T., Stepankova, R., Rossmann, P., Ridl, J., Kostovcik, M., Mrazek, J., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281330a · Cited by 93
“Myeloid differentiation factor 88 (MyD88), which is responsible for signal transduction from all TLRs except for TLR3, was shown to interfere with the pathogenesis of colon inflammation and cancer by triggering proinflammatory response through transcription factor nuclear factor kB.(14,15) Interleukin-1 (IL-1) recepto…”
BackgroundYang, Y. R., Kim, D. H., Seo, Y., Park, D., Jang, H., Choi, S. Y., Lee, Y. H., Lee, G. H., Nakajima, K., Taniguchi, N., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3725 · Cited by 99
Dunne, A., Marshall, N. A., & Mills, K. H. G. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.03.004 · Cited by 99
IL-11 Signaling as a Therapeutic Target for Cancer
Putoczki, T. L., & Ernst, M. (2015) · Immunotherapy · doi:10.2217/imt.15.17 · Cited by 97
Pearce, S. E., Weber, G. J., van Sambeek, D. M., Soares, J. W., Racicot, K., & Breault, D. T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230231 · Cited by 97
NLRP6 Protects Il10 Mice from Colitis by Limiting Colonization of Akkermansia muciniphila
Seregin, S. S., Golovchenko, N., Schaf, B., Chen, J., Pudlo, N. A., Mitchell, J., Baxter, N. T., Zhao, L., Schloss, P. D., Martens, E. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.074 · Cited by 90
Schiechl, G., Bauer, B., Fuss, I., Lang, S. A., Moser, C., Ruemmele, P., Rose-John, S., Neurath, M. F., Geissler, E. K., Schlitt, H.-J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42540 · Cited by 86
Inflammasome: Cancer's friend or foe?
Terlizzi, M., Casolaro, V., Pinto, A., & Sorrentino, R. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.002 · Cited by 97
Riva, F., Bonavita, E., Barbati, E., Muzio, M., Mantovani, A., & Garlanda, C. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00322 · Cited by 97
Singh, K., Coburn, L. A., Asim, M., Barry, D. P., Allaman, M. M., Shi, C., Washington, M. K., Luis, P. B., Schneider, C. G., Delgado, A. G., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0116 · Cited by 87
“Also confounding are findings that Tlr4 / mice exhibit less mucosal immune response and less tumor development with AOM-DSS treatment (32), yet signaling through MyD88, the main downstream effector of TLR4, reduces DNA damage and tumors in the same CAC model (33).”
BackgroundPhase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma
Davar, D., Wang, H., Chauvin, J.-M., Pagliano, O., Fourcade, J. J., Ka, M., Menna, C., Rose, A., Sander, C., Borhani, A. A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.00632 · Cited by 86
Zhou, G., Peng, K., Song, Y., Yang, W., Shu, W., Yu, T., Lin, Y., Lin, M., Wei, Q., Chen, C., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx142 · Cited by 94
The Mitochondrial Protein NLRX1 Controls the Balance between Extrinsic and Intrinsic Apoptosis
Soares, F., Tattoli, I., Rahman, M. A., Robertson, S. J., Belcheva, A., Liu, D., Streutker, C., Winer, S., Winer, D. A., Martín, A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.550111 · Cited by 92
Eyking, A., Ey, B., Rünzi, M., Roig, A. I., Reis, H., Schmid, K. W., Gerken, G., Podolsky, D. K., & Cario, E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.043 · Cited by 83
Deswaerte, V., Nguyen, P. M., West, A. C., Browning, A. F., Yu, L., Ruwanpura, S. M., Balic, J. J., Livis, T., Girard, C., Preaudet, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1887 · Cited by 91
Gatault, S., Delbeke, M., Driss, V., Sarazin, A., Dendooven, A., Kahn, J., Lefèvre, G., & Capron, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402914 · Cited by 88
Role of Nlrp6 and Nlrp12 in the maintenance of intestinal homeostasis
Chen, G. (2014) · European Journal of Immunology · doi:10.1002/eji.201344135 · Cited by 92
Kesselring, R., Gläsner, J., Hiergeist, A., Naschberger, E., Neumann, H., Brunner, S. M., Wege, A. K., Seebauer, C. T., Köhl, G., Merkl, S., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.014 · Cited by 85
“Recently it was demonstrated that TLRs and MyD88 regulate the cancerogenesis of CRCs (Abreu, 2010; Rakoff-Nahoum and Medzhitov, 2007; Salcedo et al., 2010).”
BackgroundThe Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies
Braumüller, H., Mauerer, B., Andris, J., Berlin, C., Wieder, T., & Kesselring, R. (2022) · Cells · doi:10.3390/cells12010138 · Cited by 90
“IL-1 Family IL-18 IL-5R5-IL-1R7 Activates lymphocytes to produce IFN-g, restricts ThH17 differentiation [138,139]”
BackgroundImplication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer
Singh, S., Sharma, P., Sarma, D. K., Kumawat, M., Tiwari, R. R., Verma, V., Nagpal, R., & Kumar, M. (2023) · Cancers · doi:10.3390/cancers15061913 · Cited by 91
Inflammasome inhibitors: promising therapeutic approaches against cancer
Xu, S., Li, X., Liu, Y., Xia, Y., Chang, R., & Zhang, C. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0755-0 · Cited by 86
Liu, W., Crott, J. W., Lyu, L., Pfalzer, A. C., Li, J., Choi, S.-W., Yang, Y., Mason, J. B., & Liu, Z. (2016) · Journal of Cancer · doi:10.7150/jca.15792 · Cited by 80
“some inflammation-associated cancer models (44, 45).”
NOD-like receptors in intestinal homeostasis and epithelial tissue repair
Parlato, M., & Yeretssian, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069594 · Cited by 79
“repair following injury [266,274,275].”
ResultBeneficial and Detrimental Roles of NLRs in Carcinogenesis
Janowski, A. M., Kolb, R. H., Zhang, W., & Sutterwala, F. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00370 · Cited by 84
Short-chain free-fatty acid G protein-coupled receptors in colon cancer
Moniri, N. H., & Farah, Q. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114483 · Cited by 79
DNA repair is indispensable for survival after acute inflammation
Calvo, J. A., Meira, L. B., Lee, C.-Y. I., Moroski-Erkul, C. A., Abolhassani, N., Taghizadeh, K., Eichinger, L. W., Muthupalani, S., Nordstrand, L. M., Klungland, A., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63338 · Cited by 77
Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer
Moradi‐Marjaneh, R., Hassanian, S. M., Fiuji, H., Soleimanpour, S., Ferns, G. A., Avan, A., & Khazaei, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26273 · Cited by 81
“However, TLR2 deficiency was not found to be associated with differential susceptibility to colitis or colitis associated cancer (Salcedo et al., 2010).”
BackgroundThe machinery of Nod‐like receptors: refining the paths to immunity and cell death
Saleh, M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01045.x · Cited by 71
Yuan, Q., Gu, J., Zhang, J., Liu, S., Wang, Q., Tian, T., Chen, Z., & Zhang, J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108724 · Cited by 70
NLRPs, microbiota, and gut homeostasis: unravelling the connection
Zambetti, L. P., & Mortellaro, A. (2014) · The Journal of Pathology · doi:10.1002/path.4357 · Cited by 69
“A similar increase in tumour burden was observed in the colons of AOM/DSS-treated Il18−/− and Il18r1−/− mice [39,42], further illustrating its importance during colitis-associated CRC development in this model.”
BackgroundMicrobes and Inflammation in Colorectal Cancer
Kostic, A. D., Chun, E., Meyerson, M., & Garrett, W. S. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0101 · Cited by 69
“Loss of NLRP6 increased colitis and colonic tumors in mice treated with DSS-AOM (26, 27).”
InfluentialSeregin, S. S., Golovchenko, N., Schaf, B., Chen, J., Eaton, K. A., & Chen, G. Y. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.55 · Cited by 67
“18 This discrepancy may reflect differential roles of IL-18 that is dependent on timing and context.”
Sateriale, A., Gullicksrud, J. A., Engiles, J. B., McLeod, B. I., Kugler, E. M., Henao‐Mejia, J., Zhou, T., Ring, A. M., Brodsky, I. E., Hunter, C. A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007807118 · Cited by 75
Estrogen plays an important role by influencing the NLRP3 inflammasome
Dong, W., Peng, Q., Liu, Z., Xie, Z., Guo, X., Li, Y., & Chen, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115554 · Cited by 75
(2022) · doi:10.1016/j.hsr.2021.100010 · Cited by 69
Emerging Significance of NLRs in Inflammatory Bowel Disease
Davis, B. K., Philipson, C., Hontecillas, R., Eden, K., Bassaganya-Riera, J., & Allen, I. C. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000151 · Cited by 67
Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis
Koliaraki, V., Roulis, M., & Kollias, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63917 · Cited by 76
“In contrast, a tumor-suppressive role has been demonstrated for the inflammasome/IL-18/IL-18R/ myeloid differentiation factor 88 (MYD88) axis, in the absence of which AOM/DSS-treated mice show impaired tissue repair and excessive commensal bacteria–driven inflammation and tumorigenesis (4, 5).”
Dupaul-Chicoine, J., Dagenais, M., & Saleh, M. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828dcac7 · Cited by 78
Raut, P. K., Kim, S., Choi, D. Y., Jeong, G., & Park, P. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.006 · Cited by 68
Bergmann, H., Roth, S., Pechloff, K., Kiss, E. A., Kuhn, S. P., Heikenwälder, M. F., Diefenbach, A., Greten, F. R., & Ruland, J. (2017) · European Journal of Immunology · doi:10.1002/eji.201646765 · Cited by 71
Błażejewski, A. J., Thiemann, S., Schenk, A., Pils, M. C., Gálvez, E. J. C., Roy, U., Heise, U., de Zoete, M. R., Flavell, R. A., & Strowig, T. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.058 · Cited by 75
“…members from several bacterial families not represented in our animal facility (e.g., S24-7, Desulfovibrionaceae, and Verrucomicrobia-ceae), including ones with potentially pro-inflammatory properties (i.e., Prevotellaceae, Enterobacteriaceae) (Figure 3A) (Elinav et al., 2011; Seo et al., 2015).”
InfluentialInflammasome as a promising therapeutic target for cancer
Lee, C., Do, H. T. T., Her, J., Kim, Y., Seo, D., & Rhee, I. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116593 · Cited by 69
Rationale for stimulator of interferon genes–targeted cancer immunotherapy
Rivera Vargas, T., Benoit-Lizon, I., & Apetoh, L. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.12.028 · Cited by 65
Bacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer
Coleman, O. I., & Haller, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01927 · Cited by 77
Dual functional roles of the MyD88 signaling in colorectal cancer development
Wang, L., Yu, K., Zhang, X., & Yu, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.139 · Cited by 66
Immune Chaperone gp96 Drives the Contributions of Macrophages to Inflammatory Colon Tumorigenesis
Morales, C., Rachidi, S., Hong, F., Sun, S., Ouyang, X., Wallace, C., Zhang, Y., Garret-Mayer, E., Wu, J., Liu, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1677 · Cited by 62
Gao, H., Cao, M., Yao, Y., Hu, W., Sun, H., Zhang, Y., Zeng, C., Tang, J., Luan, S., & Chen, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750841 · Cited by 65
Menghini, P., Corridoni, D., Buttó, L. F., Ösme, A., Shivaswamy, S., Lam, M. C., Bamias, G., Pizarro, T. T., Rodriguez‐Palacios, A., Dinarello, C. A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915043116 · Cited by 66
CD13 Restricts TLR4 Endocytic Signal Transduction in Inflammation
Ghosh, M., Subramani, J., Rahman, M. M., & Shapiro, L. H. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403133 · Cited by 60
“pathways result in both pro- and antihealing effects in inflammatory disease models (7, 8).”
NLRP3 inflammasome in colitis and colitis-associated colorectal cancer
Perera, A. P., Sajnani, K., Dickinson, J. L., Eri, R. D., & Körner, H. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9783-2 · Cited by 64
Davis, M. B., Vasquez-Dunddel, D., Fu, J. L., Albesiano, E., Pardoll, D., & Kim, Y. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3262 · Cited by 67
NLRP6 in host defense and intestinal inflammation
Venuprasad, K., & Theiss, A. L. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109043 · Cited by 65
“However, complete loss of IL-18, IL-18R, or components of the inflammasome predisposes mice to increased epithelial damage and potentiates colonic tumor growth (Salcedo et al., 2010; Takagi et al., 2003; Zaki et al., 2010).”
BackgroundThe IL-1 family in tumorigenesis and antitumor immunity
Sun, R., Gao, D. S., Shoush, J., & Lu, B. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.002 · Cited by 63
Assessment of bioactivities of the human milk lactoferrin–osteopontin complex in vitro
Liu, L., Jiang, R., & Lönnerdal, B. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.03.016 · Cited by 59
Gut Microbiota and Colorectal Cancer: A Balance Between Risk and Protection
Ionescu, V. A., Diaconu, C. C., Gheorghe, G., Mihai, M.-M., Diaconu, C. C., Bostan, M., & Bleoţu, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083733 · Cited by 61
“[78].”
Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression
Porta, C., Ippolito, A., Consonni, F. M., Carraro, L., Celesti, G., Correale, C., Grizzi, F., Pasqualini, F., Tartari, S., Rinaldi, M., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0036 · Cited by 59
“Because the molecular determinants of intestinal carcinogenesis may differ in models of CAC compared with genetically driven colorectal cancers (37, 38), we evaluated the role of p50 NF-kB in the Apc mouse model of spontaneous intestinal carcinogenesis (39).”
BackgroundBoersma, B., Jiskoot, W., Lowe, P. R., & Bourquin, C. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.09.004 · Cited by 62
Wu, J., Li, K., Peng, W., Li, H., Li, Q., Wang, X., Peng, Y., Tang, X., & Fu, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105724 · Cited by 62
Sánchez-Alcoholado, L., Laborda-Illanes, A., Otero, A., Ordóñez, R., González-González, A., Plaza-Andrades, I., Ramos-Molina, B., Gómez-Millán, J., & Queipo-Ortuño, M. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179549 · Cited by 49
“Moreover, butyrate has been described to be able to induce the production of IL-18 by the intestinal epithelial cells through the activation of the GPR109a receptor, which stimulates mucosal tissue repair via the regulation of the production and availability of IL-22 [57].”
BackgroundWang, Z., Zeng, F., Hu, Y., Wang, X., Zhao, F., Zhou, P., Hu, J., Xiao, Y., Hu, Z., Guo, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00820-z · Cited by 57
Sittipo, P., Lobionda, S., Choi, K., Sari, I. N., Kwon, H. Y., & Lee, Y. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01588 · Cited by 57
“One study showed that TLR2 did not affect the susceptibility to developing CRC in mice (Salcedo et al., 2010), whereas another study showed that TLR2 signaling protects against the development of tumor formation in a mouse model of colitisinduced cancer (Lowe et al.”
Background
Metadata
- Authors
- Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R.-M., Wang, E., Ma, W., Haines, D., O'hUigin, C., Marincola, F. M., & Trinchieri, G.
- Affiliations
- National Cancer Institute (US)
- National Institutes of Health (US)
- Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701 1
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Trinchieri, Giorgio
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-07-12
- Volume
- 207
- Issue
- 8
- Pages
- 1625-1636
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2916129
- OpenAlex
- W2118983602
- Cited by
- 429
- References
- 44
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 10 · 2023: 24 · 2022: 21 · 2021: 24 · 2020: 26 · 2019: 21 · 2018: 38 · 2017: 38 · 2016: 18 · 2015: 35 · 2014: 36 · 2013: 42 · 2012: 37
- FWCI
- 16.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HHSN261200800001C)
- National Cancer Institute (HHSN261200800001E))
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- MyD88 signaling, IL-18, interleukin-18 receptor, colitis-associated colorectal cancer, colon adenocarcinoma, carcinogenesis, inflammatory bowel disease, CTNNB1 mutation, adenoma formation, MyD88-deficient mice, TLR2, TLR4, tissue homeostasis
- MeSH terms
- Adenocarcinoma, Animals, Azoxymethane, Colon, Colonic Neoplasms, Colonic Polyps, Epithelial Cells, Intestinal Mucosa, Mice, Inbred C57BL, Mutation, Phosphorylation, Specific Pathogen-Free Organisms, Inflammatory Bowel Diseases, Signal Transduction, Gene Expression, Dextran Sulfate, Apoptosis, Mice, Knockout, Genetic Predisposition to Disease, Interleukin-18, Gene Expression Profiling, DNA Repair Enzymes, Cell Proliferation, STAT3 Transcription Factor, beta Catenin, Mice, Cyclooxygenase 2, Receptors, Interleukin-1 Type I, Myeloid Differentiation Factor 88, Interleukin-18 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.